Inhibition and even reversion of arterial disease in Fbn1C1041G/+ mice by lentiviral mediated Prkg1 silencing greatly contrast the relatively modest attenuation of TAA pathology observed in Fbn1C1041G/+; Nox4−/− mice [40,43]. The gene discussed is NOX4; the disease is arterial disorder.